PHARMA SIGNALOPEN RESEARCH PLATFORM →
CLINICAL TRIAL PROFILE · UPDATED 2026-09-29

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema

NCT07515079 · Phase 3 · Recruiting

PHASEPhase 3
STATUSRecruiting
ENROLLMENT406
EST. COMPLETION2027-04-30

Conditions

Diabetic Macular Edema (DME)

Interventions

BAT5906 injectionLucentis

Study details

SPONSORBio-Thera Solutions
START DATE2024-10-09

Related company profiles

Bio-Thera Solutions

688177.SS

Primary source

Trial status and dates can change. Confirm enrollment and eligibility against the linked ClinicalTrials.gov record.

Evidence & limits

Source: Open the source record

Record identifier
NCT07515079
Event / action date
Not separately retained
Source update date
Not separately retained
Platform retrieval / processing date
Not separately retained

What it supports. Study information reported by the sponsor or investigator, including status, phase, enrollment, and recorded dates.

Limits. Registration or completion does not establish clinical success or approval. Sponsor-name associations can be ambiguous. Dates may be estimated; verify the live study record.

Connection basis. Company sponsor aliases and normalized lead-sponsor containment; the NCT identifier identifies the study.

What this record means · Report an issue with this record